Latest Earnings Analysis

• Avient (AVNT) Q3 2024: Organic Sales Jump 8.5% as Share Gains and New Launches Power Top-Line
  October 31, 2024 · AVNT
• Buenaventura (BVN) Q3 2024: EBITDA Margin Jumps to 40% as Uchucchacua and Yumpag Drive Cost Reset
  October 31, 2024 · BVN
• Allstate (ALL) Q3 2024: Direct Channel New Business Surges 56% as Growth Initiatives Gain Traction
  October 31, 2024 · ALL
• Credit Acceptance (CACC) Q3 2024: Loan Portfolio Climbs 18.6% as Underwriting Discipline Counters Vintage Headwinds
  October 31, 2024 · CACC
• Amazon (AMZN) Q3 2024: AWS AI Revenue Surges 3x Faster Than Core Cloud, Fueling $75B CapEx Commitment
  October 31, 2024 · AMZN
• AMSC (AMSC) Q2 2024: Backlog Surges Past $300M as Grid and Wind Orders Accelerate
  October 31, 2024 · AMSC
• Albany International (AIN) Q3 2024: Heimbach Drives 10% Machine Clothing Lift Amid AEC Margin Reset
  October 31, 2024 · AIN
• Ardelyx (ARDX) Q3 2024: Exposa Sales Jump 39% as Medicare Bundle Uncertainty Intensifies
  October 31, 2024 · ARDX
• Agios (AGIO) Q3 2024: $1.1B Milestone Fuels Thalassemia and Sickle Cell Launch Readiness
  October 31, 2024 · AGIO
• AMETEK (AME) Q3 2024: Orders Rise 12% as Backlog Hits $3.44B, Destocking Headwinds Easing
  October 31, 2024 · AME
• ARGX Q3 2024: CIDP Launch Adds 300 Patients, Validating Switch Market Strategy
  October 31, 2024 · ARGX
• ARI Q3 2024: $953M Loan Repayments Unlock Portfolio Reinvestment Leverage
  October 31, 2024 · ARI
• BJ’s Restaurants (BJRI) Q3 2024: Pizookie Promotions Drive 1.3% Traffic Gain, Margin Recovery Hinges on Mix Discipline
  October 31, 2024 · BJRI
• Amcor (AMCR) Q1 2025: Flexibles Volumes Up 3%, Margin Expansion Signals Early Growth Leverage
  October 31, 2024 · AMCR
• Alnylam (ALNY) Q3 2024: TTR Franchise Climbs 34% as ATTR-CM Launch Preparation Accelerates
  October 31, 2024 · ALNY
• AB InBev (BUD) Q3 2024: $2B Buyback Signals Leverage Flexibility as Margin Expands 169bps
  October 31, 2024 · BUD
• BGC (BGC) Q3 2024: FMX UST Volumes Jump 40% as Energy Acquisitions Add $450M Revenue Run-Rate
  October 31, 2024 · BGC
• Antero Resources (AR) Q3 2024: Well Costs Drop 8% as Cycle Times Compress, Unlocking $500M Cash Flow Upside
  October 31, 2024 · AR
• Aflac (AFL) Q3 2024: Sumitas Drives 12% Japan Sales Growth, Signals Product-Led Diversification
  October 31, 2024 · AFL
• BorgWarner (BWA) Q3 2024: Margin Surges to 10.1% as Cost Actions Offset 5% Sales Decline
  October 31, 2024 · BWA
• APTV Q3 2024: Margin Expands 120 bps as EV Headwinds Cut 20% from Electrical Distribution
  October 31, 2024 · APTV
• AXTI (AXTI) Q3 2024: Indium Phosphide Orders Up, Germanium Revenue Set to Bottom in Q4
  October 31, 2024 · AXTI
• AXS Q3 2024: Property Lines Up 10% as Underwriting Discipline Trumps Top-Line Growth
  October 31, 2024 · AXS
• Broadstone Net Lease (BNL) Q3 2024: $405M Build-to-Suit Pipeline Secures $33M Future ABR
  October 31, 2024 · BNL
• Bristol-Myers Squibb (BMY) Q3 2024: Growth Portfolio Hits 50% of Sales as Neuroscience Launch Reshapes Outlook
  October 31, 2024 · BMY
• Agnico Eagle (AEM) Q3 2024: Free Cash Flow Surges 7x, Unlocking 45% Shareholder Return
  October 31, 2024 · AEM
• American Water (AWK) Q3 2024: $1 Billion CapEx Increase Extends 8% Rate Base Growth Trajectory
  October 31, 2024 · AWK
• Alchemy Technology (ALKT) Q3 2024: Data Product Attach Rate Climbs to 75%, Fueling Cross-Sell Momentum
  October 30, 2024 · ALKT
• Horizon Technology Finance (AVTX) Q3 2024: Portfolio Grows 6% as Backlog Hits $190M, Pipeline Surges
  October 30, 2024 · AVTX
• Avnet (AVT) Q1 2025: Asia Sales Jump 14% as Western Weakness Extends Downturn
  October 30, 2024 · AVT
• Avanos Medical (AVNS) Q3 2024: Digestive Health Grows 6% as Transformation Offsets Pain Portfolio Setbacks
  October 30, 2024 · AVNS
• BG Q3 2024: $600M Buyback and Viterra Integration Fuel Strategic Reset
  October 30, 2024 · BG
• Bausch Health (BHC) Q3 2024: Operating Cash Flow Jumps 75% as Portfolio Diversification Drives Guidance Hike
  October 30, 2024 · BHC
• BHE Q3 2024: Semi-Cap Revenue Jumps 13% as Margin Expansion Hits 16-Quarter Streak
  October 30, 2024 · BHE
• Aurora (AUR) Q3 2024: $483M Capital Raise Extends Runway, Driverless Launch Set for April
  October 30, 2024 · AUR
• ATNI Q3 2024: $35M Goodwill Impairment Underscores U.S. Telecom Reset
  October 30, 2024 · ATNI
• Biogen (BIIB) Q3 2024: Pipeline Peak Sales Targeted at $14B, Offsetting 3% Core Pharma Decline
  October 30, 2024 · BIIB
• ATEC (ATEC) Q3 2024: Operating Expense Flat for 3 Quarters as Cash Burn Drops 50%
  October 30, 2024 · ATEC
• BXP (BXP) Q3 2024: Leasing Volume Up 25% YTD, Premier Workplaces Outperform as Transaction Pipeline Grows
  October 30, 2024 · BXP
• Bio-Rad (BIO) Q3 2024: Clinical Diagnostics Up 6%, Process Chrome Destocking Persists Into 2025
  October 30, 2024 · BIO
• ASM (ASM) Q3 2024: Orders Surge 30% as Gate-All-Around Ramp Drives 2025 Visibility
  October 30, 2024 · ASM
• BXC Q3 2024: Specialty Volumes Rise Amid 19% Margin, Deflation Headwinds Persist
  October 30, 2024 · BXC
• Arvinas (ARVN) Q3 2024: Novartis Deal Adds $76.7M Revenue as Phase 3 VetDeg Data Nears Inflection
  October 30, 2024 · ARVN
• Booking Holdings (BKNG) Q3 2024: Alternative Accommodations Mix Climbs to 35% as Asia Drives Growth
  October 30, 2024 · BKNG
• Allegiant (ALGT) Q3 2024: MAX Fuel Savings to Add $2M EBITDA per Aircraft as Utilization Rebounds
  October 30, 2024 · ALGT
• Blackbaud (BLKB) Q3 2024: EverFi Down 26%, Social Sector Resilience Drives 6.6% Growth
  October 30, 2024 · BLKB
• American Assets Trust (AAT) Q3 2024: $525M Bond Locks In Liquidity, Retail Rents Hit All-Time High
  October 30, 2024 · AAT
• AbbVie (ABBV) Q3 2024: Ex-Humira Platform Grows 18% as Pipeline and Portfolio Reshape Post-LOE Trajectory
  October 30, 2024 · ABBV
• Excel Entertainment (ACEL) Q3 2024: Nebraska Hold Per Day Jumps 17% as Route Optimization Accelerates
  October 30, 2024 · ACEL
• ADP (ADP) Q1 2025: Workforce Software Acquisition Drives 1% Revenue Guidance Lift, Expands Global HCM Reach
  October 30, 2024 · ADP